Active	Status	Sponsor type	Region	Phase	Filter
23 Active 7 Inactive 30 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
CHEVALIER, Nicolas
SURMOUNT-MMO, NCT05556512: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity	Active, not recruiting	3	15374	Europe, Canada, Japan, US, RoW	Tirzepatide, LY3298176, Placebo	Eli Lilly and Company	Obesity, Overweight	10/27	10/27
NCT05893797: A Study of LY8888AX in Participants Using a Connected Insulin Management Platform	Completed	N/A	36	Europe	Insulin Lispro, Humalog Tempo Pen, Tempo Smart Button, Dexcom G6 CGM, Glooko Research Medical App (RMA)	Eli Lilly and Company	Type 1 Diabetes, Type 2 Diabetes, Type 2 Diabetes Treated With Insulin	09/24	09/24
HOFLACK, Marie
No trials found
HAAS, Hervé
No trials found
Brue, Thierry
No trials found
Fagot, Eléanore
No trials found
Pautasso, Valentina
No trials found
Nicolau-Langlade, Sylvie
No trials found
Decoux-Poullot, Anne-Gaëlle
No trials found
Telo, Stéphanie
No trials found